|
Volume 271, Number 23,
Issue of June 7, 1996
pp. 13308-13316
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Role of Phosphorylation on DNA Binding and Transcriptional
Functions of Human Progesterone Receptors
(Received for publication, December 6, 1995, and in revised form, March 29, 1996)
Glenn S.
Takimoto
,
Alicia Rudie
Hovland
§
,
Diane M.
Tasset
,
Mary Y.
Melville
,
Lin
Tung
and
Kathryn B.
Horwitz
§''
From the Departments of Medicine and '' Pathology and
the § Molecular Biology Program, Division of Endocrinology,
Metabolism and Diabetes, University of Colorado Health Sciences Center,
Denver, Colorado 80262
To study the function of human progesterone
receptor (hPR) phosphorylation, we have tested four sets of serine to
alanine substitution mutants: 10 serine clusters, located in regions
common to both hPR isoforms (the M-series mutants) were mutated in
A-receptors and B-receptors; 6 serine clusters located in the
B-upstream segment (BUS; the B-series mutants) were mutated
individually and collectively and cloned into B-receptors and into
BUS-DBD-NLS, a constitutive transactivator, in which the AF3 function
of BUS is fused to the DNA binding domain (DBD) and nuclear
localization signal (NLS) of hPR. Transcription by most of the M-series
mutants resembles that of wild-type A- or B-receptors. Mutation of 3 sites, Ser190 at the N terminus of A-receptors, a cluster
of serines just upstream of the DBD, or Ser676 in the hinge
region, inhibits transcription by 20-50% depending on cell or
promoter context. These sites lie outside the AF1 activation function.
M-series mutants are substrates for a hormone-dependent
phosphorylation step, and they all bind well to DNA. Progressive
mutation of the B-series clusters leads to the gradual
dephosphorylation of BUS, but only the 6-site mutant, involving 10 serine residues, is completely dephosphorylated. These data suggest
that in BUS alternate serines are phosphorylated or dephosphorylated at
any time. However, even when BUS is completely dephosphorylated, both
BUS-DBD-NLS and full-length B-receptors remain strong transactivators.
Mutant B-receptors also do not acquire the dominant negative properties
of A-receptors, and they retain the ability to activate transcription
in synergy with 8-Br-cAMP and antiprogestins. We conclude that
phosphorylation has subtle effects on the complex transcriptional
repertoire that distinguishes the two hPR isoforms and does not
influence transactivation mediated by AF1 or AF3, but subserves other
functions.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. E Dressing, C. R Hagan, T. P Knutson, A. R Daniel, and C. A Lange
Progesterone receptors act as sensors for mitogenic protein kinases in breast cancer models
Endocr. Relat. Cancer,
June 1, 2009;
16(2):
351 - 361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Abdel-Hafiz, M. L. Dudevoir, and K. B. Horwitz
Mechanisms Underlying the Control of Progesterone Receptor Transcriptional Activity by SUMOylation
J. Biol. Chem.,
April 3, 2009;
284(14):
9099 - 9108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Romano, B. Delvoux, D.-C. Fischer, and P. Groothuis
The PROGINS polymorphism of the human progesterone receptor diminishes the response to progesterone
J. Mol. Endocrinol.,
February 1, 2007;
38(2):
331 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. U. Agoulnik, X.-W. Tong, D.-C. Fischer, K. Korner, N. E. Atkinson, D. P. Edwards, D. R. Headon, N. L. Weigel, and D. G. Kieback
A Germline Variation in the Progesterone Receptor Gene Increases Transcriptional Activity and May Modify Ovarian Cancer Risk
J. Clin. Endocrinol. Metab.,
December 1, 2004;
89(12):
6340 - 6347.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Lange
Making Sense of Cross-Talk between Steroid Hormone Receptors and Intracellular Signaling Pathways: Who Will Have the Last Word?
Mol. Endocrinol.,
February 1, 2004;
18(2):
269 - 278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Qiu, A. Olsen, E. Faivre, K. B. Horwitz, and C. A. Lange
Mitogen-Activated Protein Kinase Regulates Nuclear Association of Human Progesterone Receptors
Mol. Endocrinol.,
April 1, 2003;
17(4):
628 - 642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Labriola, M. Salatino, C. J. Proietti, A. Pecci, O. A. Coso, A. R. Kornblihtt, E. H. Charreau, and P. V. Elizalde
Heregulin Induces Transcriptional Activation of the Progesterone Receptor by a Mechanism That Requires Functional ErbB-2 and Mitogen-Activated Protein Kinase Activation in Breast Cancer Cells
Mol. Cell. Biol.,
February 1, 2003;
23(3):
1095 - 1111.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
H. Abdel-Hafiz, G. S. Takimoto, L. Tung, and K. B. Horwitz
The Inhibitory Function in Human Progesterone Receptor N Termini Binds SUMO-1 Protein to Regulate Autoinhibition and Transrepression
J. Biol. Chem.,
September 6, 2002;
277(37):
33950 - 33956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Gioeli, S. B. Ficarro, J. J. Kwiek, D. Aaronson, M. Hancock, A. D. Catling, F. M. White, R. E. Christian, R. E. Settlage, J. Shabanowitz, et al.
Androgen Receptor Phosphorylation. REGULATION AND IDENTIFICATION OF THE PHOSPHORYLATION SITES
J. Biol. Chem.,
August 2, 2002;
277(32):
29304 - 29314.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Tung, T. Shen, M. G. Abel, R. L. Powell, G. S. Takimoto, C. A. Sartorius, and K. B. Horwitz
Mapping the Unique Activation Function 3 in the Progesterone B-receptor Upstream Segment. TWO LXXLL MOTIFS AND A TRYPTOPHAN RESIDUE ARE REQUIRED FOR ACTIVITY
J. Biol. Chem.,
October 19, 2001;
276(43):
39843 - 39851.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tian, S. Kim, E. Heilig, and J. V. Ruderman
Identification of XPR-1, a progesterone receptor required for Xenopus oocyte activation
PNAS,
December 8, 2000;
(2000)
250492197.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. A. Lange, T. Shen, and K. B. Horwitz
Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals their degradation by the 26S proteasome
PNAS,
February 1, 2000;
97(3):
1032 - 1037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Clemm, L. Sherman, V. Boonyaratanakornkit, W. T. Schrader, N. L. Weigel, and D. P. Edwards
Differential Hormone-Dependent Phosphorylation of Progesterone Receptor A and B Forms Revealed by a Phosphoserine Site-Specific Monoclonal Antibody
Mol. Endocrinol.,
January 1, 2000;
14(1):
52 - 65.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. J. Brosens, N. Hayashi, and J. O. White
Progesterone Receptor Regulates Decidual Prolactin Expression in Differentiating Human Endometrial Stromal Cells
Endocrinology,
October 1, 1999;
140(10):
4809 - 4820.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. K. Hodges, J. K. Richer, K. B. Horwitz, and L. D. Horwitz
Variant Estrogen and Progesterone Receptor Messages in Human Vascular Smooth Muscle
Circulation,
May 25, 1999;
99(20):
2688 - 2693.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Lim, C. T. Baumann, H. Htun, W. Xian, M. Irie, C. L. Smith, and G. L. Hager
Differential Localization and Activity of the A- and B-Forms of the Human Progesterone Receptor Using Green Fluorescent Protein Chimeras
Mol. Endocrinol.,
March 1, 1999;
13(3):
366 - 375.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Chen, P. E. Pace, R. C. Coombes, and S. Ali
Phosphorylation of Human Estrogen Receptor alpha by Protein Kinase A Regulates Dimerization
Mol. Cell. Biol.,
February 1, 1999;
19(2):
1002 - 1015.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Hovland, R. L. Powell, G. S. Takimoto, L. Tung, and K. B. Horwitz
An N-terminal Inhibitory Function, IF, Suppresses Transcription by the A-isoform but Not the B-isoform of Human Progesterone Receptors
J. Biol. Chem.,
March 6, 1998;
273(10):
5455 - 5460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kahmann, L. Vaßen, and L. Klein-Hitpass
Synergistic Enhancement of PRB-Mediated RU486 and R5020 Agonist Activities through Cyclic Adenosine 3',5'-Monophosphate Represents a Delayed Primary Response
Mol. Endocrinol.,
February 1, 1998;
12(2):
278 - 289.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Zhang, C. A. Beck, A. Poletti, J. P. Clement IV, P. Prendergast, T.-T. Yip, T. W. Hutchens, D. P. Edwards, and N. L. Weigel
Phosphorylation of Human Progesterone Receptor by Cyclin-Dependent Kinase 2 on Three Sites That Are Authentic Basal Phosphorylation Sites In Vivo
Mol. Endocrinol.,
June 1, 1997;
11(6):
823 - 832.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. A. Knotts, R. S. Orkiszewski, R. G. Cook, D. P. Edwards, and N. L. Weigel
Identification of a Phosphorylation Site in the Hinge Region of the Human Progesterone Receptor and Additional Amino-terminal Phosphorylation Sites
J. Biol. Chem.,
March 9, 2001;
276(11):
8475 - 8483.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tian, S. Kim, E. Heilig, and J. V. Ruderman
Identification of XPR-1, a progesterone receptor required for Xenopus oocyte activation
PNAS,
December 19, 2000;
97(26):
14358 - 14363.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|